APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA COVID-19 Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global mRNA COVID-19 Vaccine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchmRNA COVID-19 Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA COVID-19 Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal mRNA COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA COVID-19 Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA COVID-19 Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global mRNA COVID-19 Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for mRNA COVID-19 Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for mRNA COVID-19 Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for mRNA COVID-19 Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for mRNA COVID-19 Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of mRNA COVID-19 Vaccine include CSPC Pharmaceutical, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical and Moderna, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for mRNA COVID-19 Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of mRNA COVID-19 Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA COVID-19 Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the mRNA COVID-19 Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global mRNA COVID-19 Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for mRNA COVID-19 Vaccine sales, projected growth trends, production technology, application and end-user industry.

mRNA COVID-19 Vaccine Segment by Company

CSPC Pharmaceutical

CanSino Biologicals

Pfizer

Fosun-Pharmaceutical

Moderna

mRNA COVID-19 Vaccine Segment by Type

Non-replicating mRNA Vaccine

Self-amplifying mRNA Vaccine

mRNA COVID-19 Vaccine Segment by Application

Children

Adults

mRNA COVID-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA COVID-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of mRNA COVID-19 Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of mRNA COVID-19 Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA COVID-19 Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global mRNA COVID-19 Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Non-replicating mRNA Vaccine Major Manufacturers Table 3. Self-amplifying mRNA Vaccine Major Manufacturers Table 4. Global mRNA COVID-19 Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Children Major Manufacturers Table 6. Adults Major Manufacturers Table 7. mRNA COVID-19 Vaccine Industry Trends Table 8. mRNA COVID-19 Vaccine Industry Drivers Table 9. mRNA COVID-19 Vaccine Industry Opportunities and Challenges Table 10. mRNA COVID-19 Vaccine Industry Restraints Table 11. Global mRNA COVID-19 Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global mRNA COVID-19 Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global mRNA COVID-19 Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global mRNA COVID-19 Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global mRNA COVID-19 Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global mRNA COVID-19 Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2026) Table 20. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2027-2032) Table 21. Global mRNA COVID-19 Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global mRNA COVID-19 Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global mRNA COVID-19 Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global mRNA COVID-19 Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global mRNA COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global mRNA COVID-19 Vaccine Manufacturers, Product Type & Application Table 29. Global mRNA COVID-19 Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global mRNA COVID-19 Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global mRNA COVID-19 Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global mRNA COVID-19 Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2026) Table 41. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2027-2032) Table 42. Global mRNA COVID-19 Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global mRNA COVID-19 Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global mRNA COVID-19 Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global mRNA COVID-19 Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2026) Table 53. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2027-2032) Table 54. Global mRNA COVID-19 Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global mRNA COVID-19 Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. CSPC Pharmaceutical Company Information Table 57. CSPC Pharmaceutical Business Overview Table 58. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio Table 60. CSPC Pharmaceutical Recent Development Table 61. CanSino Biologicals Company Information Table 62. CanSino Biologicals Business Overview Table 63. CanSino Biologicals mRNA COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio Table 65. CanSino Biologicals Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer mRNA COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Pfizer mRNA COVID-19 Vaccine Product Portfolio Table 70. Pfizer Recent Development Table 71. Fosun-Pharmaceutical Company Information Table 72. Fosun-Pharmaceutical Business Overview Table 73. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio Table 75. Fosun-Pharmaceutical Recent Development Table 76. Moderna Company Information Table 77. Moderna Business Overview Table 78. Moderna mRNA COVID-19 Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Moderna mRNA COVID-19 Vaccine Product Portfolio Table 80. Moderna Recent Development Table 81. North America mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 82. North America mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 83. North America mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 84. North America mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 85. North America mRNA COVID-19 Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 86. North America mRNA COVID-19 Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 87. North America mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 88. North America mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 89. North America mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 90. North America mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 91. North America mRNA COVID-19 Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 92. North America mRNA COVID-19 Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 93. North America mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 97. North America mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 98. North America mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 99. North America mRNA COVID-19 Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 100. North America mRNA COVID-19 Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 101. United States mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 102. Canada mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 103. Mexico mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 104. Europe mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 107. Europe mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 108. Europe mRNA COVID-19 Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 109. Europe mRNA COVID-19 Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 110. Europe mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 113. Europe mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 114. Europe mRNA COVID-19 Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 115. Europe mRNA COVID-19 Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 116. Europe mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 120. Europe mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 121. Europe mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 122. Europe mRNA COVID-19 Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 123. Europe mRNA COVID-19 Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 124. Germany mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 125. France mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 126. U.K. mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Italy mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Russia mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Spain mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 130. Netherlands mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 131. Switzerland mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 132. Sweden mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 133. Poland mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 134. China mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 135. China mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 136. China mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 137. China mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 138. China mRNA COVID-19 Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 139. China mRNA COVID-19 Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 140. China mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 141. China mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 142. China mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 143. China mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 144. China mRNA COVID-19 Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 145. China mRNA COVID-19 Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 146. Asia mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 149. Asia mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 150. Asia mRNA COVID-19 Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 151. Asia mRNA COVID-19 Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 152. Asia mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 155. Asia mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 156. Asia mRNA COVID-19 Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 157. Asia mRNA COVID-19 Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 158. Asia mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 162. Asia mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 163. Asia mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 164. Asia mRNA COVID-19 Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 165. Asia mRNA COVID-19 Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 166. Japan mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 167. South Korea mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 168. India mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Australia mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 170. Taiwan mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 172. SAMEA mRNA COVID-19 Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA mRNA COVID-19 Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA mRNA COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 175. SAMEA mRNA COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 176. SAMEA mRNA COVID-19 Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 177. SAMEA mRNA COVID-19 Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 178. SAMEA mRNA COVID-19 Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA mRNA COVID-19 Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA mRNA COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 181. SAMEA mRNA COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 182. SAMEA mRNA COVID-19 Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 183. SAMEA mRNA COVID-19 Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 184. SAMEA mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 188. SAMEA mRNA COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 189. SAMEA mRNA COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 190. SAMEA mRNA COVID-19 Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 191. SAMEA mRNA COVID-19 Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 192. Brazil mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Argentina mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 194. Chile mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Colombia mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Peru mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Israel mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 199. UAE mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 200. Turkey mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 201. Iran mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 202. Egypt mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. mRNA COVID-19 Vaccine Distributors List Table 206. mRNA COVID-19 Vaccine Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. mRNA COVID-19 Vaccine Image Figure 2. Global mRNA COVID-19 Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA COVID-19 Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Non-replicating mRNA Vaccine Image Figure 5. Self-amplifying mRNA Vaccine Image Figure 6. Global mRNA COVID-19 Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global mRNA COVID-19 Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Children Image Figure 9. Adults Image Figure 10. Global mRNA COVID-19 Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global mRNA COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global mRNA COVID-19 Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global mRNA COVID-19 Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global mRNA COVID-19 Vaccine Sales (2021-2032) & (k units) Figure 16. Global mRNA COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico mRNA COVID-19 Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe mRNA COVID-19 Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China mRNA COVID-19 Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) mRNA COVID-19 Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa mRNA COVID-19 Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global mRNA COVID-19 Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global mRNA COVID-19 Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global mRNA COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global mRNA COVID-19 Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global mRNA COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global mRNA COVID-19 Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global mRNA COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global mRNA COVID-19 Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global mRNA COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global mRNA COVID-19 Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America mRNA COVID-19 Vaccine Revenue Share by Type (2021-2032) Figure 39. North America mRNA COVID-19 Vaccine Sales Share by Type (2021-2032) Figure 40. North America mRNA COVID-19 Vaccine Revenue Share by Application (2021-2032) Figure 41. North America mRNA COVID-19 Vaccine Sales Share by Application (2021-2032) Figure 42. North America mRNA COVID-19 Vaccine Revenue Share by Country (2021-2032) Figure 43. North America mRNA COVID-19 Vaccine Sales Share by Country (2021-2032) Figure 44. Europe mRNA COVID-19 Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe mRNA COVID-19 Vaccine Sales Share by Type (2021-2032) Figure 46. Europe mRNA COVID-19 Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe mRNA COVID-19 Vaccine Sales Share by Application (2021-2032) Figure 48. Europe mRNA COVID-19 Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe mRNA COVID-19 Vaccine Sales Share by Country (2021-2032) Figure 50. China mRNA COVID-19 Vaccine Revenue Share by Type (2021-2032) Figure 51. China mRNA COVID-19 Vaccine Sales Share by Type (2021-2032) Figure 52. China mRNA COVID-19 Vaccine Revenue Share by Application (2021-2032) Figure 53. China mRNA COVID-19 Vaccine Sales Share by Application (2021-2032) Figure 54. Asia mRNA COVID-19 Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia mRNA COVID-19 Vaccine Sales Share by Type (2021-2032) Figure 56. Asia mRNA COVID-19 Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia mRNA COVID-19 Vaccine Sales Share by Application (2021-2032) Figure 58. Asia mRNA COVID-19 Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia mRNA COVID-19 Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA mRNA COVID-19 Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA mRNA COVID-19 Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA mRNA COVID-19 Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA mRNA COVID-19 Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA mRNA COVID-19 Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA mRNA COVID-19 Vaccine Sales Share by Country (2021-2032) Figure 66. mRNA COVID-19 Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. mRNA COVID-19 Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Non-replicating mRNA Vaccine
  • Self-amplifying mRNA Vaccine
Applications
  • Children
  • Adults
Companies covered
  • CSPC Pharmaceutical
  • CanSino Biologicals
  • Pfizer
  • Fosun-Pharmaceutical
  • Moderna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 mRNA COVID-19 Vaccine Market by Type
  3. 1.2.1 Global mRNA COVID-19 Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Non-replicating mRNA Vaccine
  5. 1.2.3 Self-amplifying mRNA Vaccine
  6. 1.3 mRNA COVID-19 Vaccine Market by Application
  7. 1.3.1 Global mRNA COVID-19 Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Children
  9. 1.3.3 Adults
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 mRNA COVID-19 Vaccine Market Dynamics
  1. 2.1 mRNA COVID-19 Vaccine Industry Trends
  2. 2.2 mRNA COVID-19 Vaccine Industry Drivers
  3. 2.3 mRNA COVID-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 mRNA COVID-19 Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global mRNA COVID-19 Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global mRNA COVID-19 Vaccine Revenue by Region
  3. 3.2.1 Global mRNA COVID-19 Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global mRNA COVID-19 Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global mRNA COVID-19 Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global mRNA COVID-19 Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global mRNA COVID-19 Vaccine Sales by Region
  9. 3.4.1 Global mRNA COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global mRNA COVID-19 Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global mRNA COVID-19 Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global mRNA COVID-19 Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global mRNA COVID-19 Vaccine Revenue by Manufacturers
  2. 4.1.1 Global mRNA COVID-19 Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global mRNA COVID-19 Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global mRNA COVID-19 Vaccine Sales by Manufacturers
  6. 4.2.1 Global mRNA COVID-19 Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global mRNA COVID-19 Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global mRNA COVID-19 Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global mRNA COVID-19 Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global mRNA COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global mRNA COVID-19 Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global mRNA COVID-19 Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global mRNA COVID-19 Vaccine Market CR5 and HHI
  16. 4.8.2 2025 mRNA COVID-19 Vaccine Tier 1, Tier 2, and Tier 3
5 mRNA COVID-19 Vaccine Market by Type
  1. 5.1 Global mRNA COVID-19 Vaccine Revenue by Type
  2. 5.1.1 Global mRNA COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global mRNA COVID-19 Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global mRNA COVID-19 Vaccine Sales by Type
  6. 5.2.1 Global mRNA COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global mRNA COVID-19 Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global mRNA COVID-19 Vaccine Price by Type
6 mRNA COVID-19 Vaccine Market by Application
  1. 6.1 Global mRNA COVID-19 Vaccine Revenue by Application
  2. 6.1.1 Global mRNA COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global mRNA COVID-19 Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global mRNA COVID-19 Vaccine Sales by Application
  6. 6.2.1 Global mRNA COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global mRNA COVID-19 Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global mRNA COVID-19 Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global mRNA COVID-19 Vaccine Price by Application
7 Company Profiles
  1. 7.1 CSPC Pharmaceutical
  2. 7.1.1 CSPC Pharmaceutical Company Information
  3. 7.1.2 CSPC Pharmaceutical Business Overview
  4. 7.1.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
  6. 7.1.5 CSPC Pharmaceutical Recent Developments
  7. 7.2 CanSino Biologicals
  8. 7.2.1 CanSino Biologicals Company Information
  9. 7.2.2 CanSino Biologicals Business Overview
  10. 7.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio
  12. 7.2.5 CanSino Biologicals Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer mRNA COVID-19 Vaccine Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Fosun-Pharmaceutical
  20. 7.4.1 Fosun-Pharmaceutical Company Information
  21. 7.4.2 Fosun-Pharmaceutical Business Overview
  22. 7.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio
  24. 7.4.5 Fosun-Pharmaceutical Recent Developments
  25. 7.5 Moderna
  26. 7.5.1 Moderna Company Information
  27. 7.5.2 Moderna Business Overview
  28. 7.5.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Moderna mRNA COVID-19 Vaccine Product Portfolio
  30. 7.5.5 Moderna Recent Developments
8 North America
  1. 8.1 North America mRNA COVID-19 Vaccine Market Size by Type
  2. 8.1.1 North America mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America mRNA COVID-19 Vaccine Price by Type (2021-2032)
  5. 8.2 North America mRNA COVID-19 Vaccine Market Size by Application
  6. 8.2.1 North America mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America mRNA COVID-19 Vaccine Price by Application (2021-2032)
  9. 8.3 North America mRNA COVID-19 Vaccine Market Size by Country
  10. 8.3.1 North America mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America mRNA COVID-19 Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe mRNA COVID-19 Vaccine Market Size by Type
  2. 9.1.1 Europe mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe mRNA COVID-19 Vaccine Price by Type (2021-2032)
  5. 9.2 Europe mRNA COVID-19 Vaccine Market Size by Application
  6. 9.2.1 Europe mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe mRNA COVID-19 Vaccine Price by Application (2021-2032)
  9. 9.3 Europe mRNA COVID-19 Vaccine Market Size by Country
  10. 9.3.1 Europe mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe mRNA COVID-19 Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China mRNA COVID-19 Vaccine Market Size by Type
  2. 10.1.1 China mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China mRNA COVID-19 Vaccine Price by Type (2021-2032)
  5. 10.2 China mRNA COVID-19 Vaccine Market Size by Application
  6. 10.2.1 China mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China mRNA COVID-19 Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia mRNA COVID-19 Vaccine Market Size by Type
  2. 11.1.1 Asia mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia mRNA COVID-19 Vaccine Price by Type (2021-2032)
  5. 11.2 Asia mRNA COVID-19 Vaccine Market Size by Application
  6. 11.2.1 Asia mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia mRNA COVID-19 Vaccine Price by Application (2021-2032)
  9. 11.3 Asia mRNA COVID-19 Vaccine Market Size by Country
  10. 11.3.1 Asia mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia mRNA COVID-19 Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA mRNA COVID-19 Vaccine Market Size by Type
  2. 12.1.1 SAMEA mRNA COVID-19 Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA mRNA COVID-19 Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA mRNA COVID-19 Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA mRNA COVID-19 Vaccine Market Size by Application
  6. 12.2.1 SAMEA mRNA COVID-19 Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA mRNA COVID-19 Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA mRNA COVID-19 Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA mRNA COVID-19 Vaccine Market Size by Country
  10. 12.3.1 SAMEA mRNA COVID-19 Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA mRNA COVID-19 Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA mRNA COVID-19 Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 mRNA COVID-19 Vaccine Value Chain Analysis
  2. 13.1.1 mRNA COVID-19 Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 mRNA COVID-19 Vaccine Production Mode & Process
  6. 13.2 mRNA COVID-19 Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 mRNA COVID-19 Vaccine Distributors
  9. 13.2.3 mRNA COVID-19 Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst